BioCentury
ARTICLE | Clinical News

DPX-RSV: Phase I start

January 26, 2015 8:00 AM UTC

This half, Immunovaccine will begin an observer-blind, placebo-controlled, Canadian Phase I trial to evaluate 2 dose levels of intramuscular DPX-RSV in about 40 healthy volunteers ages 50-64. ...